Patents by Inventor Stefan Andreas

Stefan Andreas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150294423
    Abstract: The present disclosure is directed towards systems and methods for flexible field mapping between disparate systems, which comprises generating a base mapping request comprising a base mapping between a source data object having one or more source data fields and a target data object having one or more target data fields and generating a field mapping request comprising a field mapping between a given source data field and a given target data field. One or more data items are identified from the target data object responsive to the base mapping request and the field mapping request. A combined request is then generated comprising the one or more data items responsive to the base mapping request and the field mapping request. The combined request is transmitted to a target memory. One or more tax values responsive to the combined request are subsequently calculated based on the one or more data items.
    Type: Application
    Filed: April 14, 2014
    Publication date: October 15, 2015
    Applicant: Thomson Reuters (Markets) LLC
    Inventors: Stefan Andreas Blumer, Jennifer Hunsicker, Neelima Kasa, Richard Allen Padur, Jacob Laux Taber
  • Publication number: 20150273978
    Abstract: A method is provided for operating a heat accumulator of a motor vehicle. Accordingly, following a start of the motor vehicle, a length and/or duration of a distance to be driven by the motor vehicle are/is ascertained or estimated. Depending on the length and/or the duration, a decision is made as to whether discharging of the heat accumulator will be carried out.
    Type: Application
    Filed: March 31, 2015
    Publication date: October 1, 2015
    Inventors: Andreas WAGNER, Rainer SCHNURR, Juergen BIESTER, Michael GLORA, Udo SCHULZ, Stefan Andreas KNIEP, Joerg HEYSE, Judith HARL-MITTENDORFER
  • Patent number: 9085555
    Abstract: The present invention provides a compound of formula I: a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
    Type: Grant
    Filed: January 2, 2012
    Date of Patent: July 21, 2015
    Assignee: NOVARTIS AG
    Inventors: Eva Altmann, Ulrich Hommel, Edwige Liliane Jeanne Lorthiois, Juergen Klaus Maibaum, Nils Ostermann, Jean Quancard, Stefan Andreas Randl, Oliver Simic, Anna Vulpetti, Véronique Stark-Rogel
  • Publication number: 20150190457
    Abstract: The present invention provides a compound of formula (I) a method for manufacturing the compounds of the invention, and its therapeutic uses as complement pathway modulators for the treatment of ocular diseases. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
    Type: Application
    Filed: June 27, 2013
    Publication date: July 9, 2015
    Applicant: NOVARTIS AG
    Inventors: Eva Altmann, Ulrich Hommel, Edwige Liliane Jeanne Lorthiois, Jeurgen Klaus Maibaum, Nils Ostermann, Jean Quancard, Stefan Andreas Randl, Olivier Rogel, Anna Vulpetti
  • Publication number: 20150191462
    Abstract: The present invention provides a compound of formula I: (I) a method for manufacturing the compounds of the invention, and its therapeutic uses as complement alternative inhibitors for the treatment of ocular diseases. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
    Type: Application
    Filed: June 27, 2013
    Publication date: July 9, 2015
    Applicant: NOVARTIS AG
    Inventors: Ulrich Hommel, Edwige Liliane Jeanne Lorthiois, Jeurgen Klaus Maibaum, Nils Ostermann, Stefan Andreas Randl, Olivier Rogel, Anna Vulpetti
  • Publication number: 20150166578
    Abstract: The present invention provides a compound of formula (I) a method for manufacturing the compounds of the invention and its therapeutic uses as complement pathway modulators for the treatment of ocular diseases. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
    Type: Application
    Filed: June 27, 2013
    Publication date: June 18, 2015
    Applicant: NOVARTIS AG
    Inventors: Eva Altmann, Ulrich Hommel, Edwige Liliane Jeanne Lorthiois, Jeurgen Klaus Maibaum, Nils Ostermann, Stefan Andreas Randl, Olivier Rogel, Anna Vulpetti
  • Publication number: 20150148349
    Abstract: The present invention provides a compound of formula (I): a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
    Type: Application
    Filed: June 27, 2013
    Publication date: May 28, 2015
    Applicant: NOVARTIS AG
    Inventors: Eva Altmann, Ulrich Hommel, Edwige Liliane Jeanne Lorthiois, Jeurgen Klaus Maibaum, Nils Ostermann, Jean Quancard, Stefan Andreas Randl, Olivier Rogel, Anna Vulpetti
  • Publication number: 20150148374
    Abstract: The present invention provides a compound of formula I: a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
    Type: Application
    Filed: June 27, 2013
    Publication date: May 28, 2015
    Applicant: NOVARTIS AG
    Inventors: Ulrich Hommel, Edwige Liliane Jeanne Lorthiois, Jeurgen Klaus Maibaum, Nils Ostermann, Stefan Andreas Randl, Olivier Rogel, Anna Vulpetti
  • Publication number: 20150141455
    Abstract: The present invention provides a compound of formula I: (I) a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
    Type: Application
    Filed: June 27, 2013
    Publication date: May 21, 2015
    Applicant: NOVARTIS AG
    Inventors: Eva Altmann, Ulrich Hommel, Edwige Liliane Jeanne Lorthiois, Jeurgen Klaus Maibaum, Nils Ostermann, Jean Quancard, Stefan Andreas Randl, Olivier Rogel, Anna Vulpetti
  • Publication number: 20150126492
    Abstract: The present invention provides a compound of formula I a method for manufacturing the compounds of the invention, and its therapeutic uses as inhibitor of the complement alternative pathway and particularly as inhibitor of Factor B for the treatment of e.g. age-related macular degeneration and diabetic retinopathy. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
    Type: Application
    Filed: June 19, 2013
    Publication date: May 7, 2015
    Applicant: NOVARTIS AG
    Inventors: Michael Dechantsreiter, Jonathan E. Grob, Aengus Macsweeney, Wolfgang Miltz, Stefan Andreas Randl, Richard Sedrani, Holger Sellner, Finton Sirockin, Eric Valeur
  • Publication number: 20150105958
    Abstract: A method for controlling an internal combustion engine and an E-machine of a hybrid electrical vehicle. In this case, the control of the internal combustion engine takes place as a function of a current and an expected waste heat of an electrical drive of the hybrid electrical vehicle.
    Type: Application
    Filed: October 15, 2014
    Publication date: April 16, 2015
    Applicant: Robert Bosch GmbH
    Inventors: Rainer SCHNURR, Juergen BIESTER, Michael GLORA, Stefan Andreas KNIEP, Joerg HEYSE
  • Publication number: 20150061550
    Abstract: A method for electrically regenerating an electrical energy store in a motor vehicle which includes a recuperation device and/or other energy-saving devices, including the following: based on information concerning an upcoming travel route, it is ascertained whether a suitable opportunity exists for an electrical regeneration on the upcoming travel route, and when this is the case: a first energy loss is determined which occurs during the electrical regeneration; a second energy loss is determined which results on a plurality of previously determined and defined routes due to aging effects of the energy store which are reversible with the aid of regeneration; the first energy loss and the second energy loss are compared, and a regeneration is carried out only when the second energy loss is greater than the first energy loss.
    Type: Application
    Filed: August 27, 2014
    Publication date: March 5, 2015
    Applicant: Robert Bosch GmbH
    Inventors: Udo SCHULZ, Jochen Pflueger, Stefan Andreas Kniep
  • Publication number: 20140244713
    Abstract: Techniques are disclosed for facilitating the process of undoing and redoing modifications that are made to content using an online content management system (CMS). As a user makes changes to content, such as by editing a webpage using a web-based CMS, a history of the user's modifications is generated and stored locally on the client. When the user invokes an undo command, the modification history can be used to determine a previous state of the content and restore the content to that previous state. Similarly, when the user invokes a redo command, the modification history can be used to return to a state that had previously been undone. In some embodiments, the process of undoing or redoing the user's modifications is selectively performed on either a client side or a server side of the online system, depending on the type of content that is being manipulated.
    Type: Application
    Filed: February 22, 2013
    Publication date: August 28, 2014
    Applicant: ADOBE SYSTEMS INCORPORATED
    Inventors: Stefan Andreas Grimm, David Benjamin Nuescheler
  • Patent number: 8809729
    Abstract: A system for determining accessibility of a tool to an object is provided. The system provides for selecting one or more sections on the object to be laser shock peened, selecting a region of interest on the one or more sections and determining a set of feasible solutions to access the selected region of interest on each of the one or more sections via use of an accessibility system.
    Type: Grant
    Filed: June 10, 2013
    Date of Patent: August 19, 2014
    Assignee: General Electric Company
    Inventors: Mark Samuel Bailey, Michelle Rene Bezdecny, Stefan Andreas Moser
  • Publication number: 20140093418
    Abstract: The invention relates to a part for a component for high-pressure liquid chromatography (HPLC), in particular a pump head for an HPLC pump, in which the strength has been increased by autofrettage and which consists of a material which is essentially chemically inert to the fluids used in HPLC. The invention further relates to an HPLC pump having a pump head which is configured as such a part.
    Type: Application
    Filed: April 16, 2012
    Publication date: April 3, 2014
    Applicant: DIONEX SOFTRON GMBH
    Inventors: Adolf Satzinger, Richard Schloderer, Stefan Andreas Seitz
  • Publication number: 20130270231
    Abstract: A system for determining accessibility of a tool to an object is provided. The system provides for selecting one or more sections on the object to be laser shock peened, selecting a region of interest on the one or more sections and determining a set of feasible solutions to access the selected region of interest on each of the one or more sections via use of an accessibility system.
    Type: Application
    Filed: June 10, 2013
    Publication date: October 17, 2013
    Inventors: Mark Samuel Bailey, Michelle Rene Bezdecny, Stefan Andreas Moser
  • Patent number: 8461477
    Abstract: A method for determining accessibility of a tool to an object is provided. The method provides for selecting one or more sections on the object to be laser shock peened, selecting a region of interest on the one or more sections and determining a set of feasible solutions to access the selected region of interest on each of the one or more sections via use of an accessibility system. Systems and computer programs that afford functionality of the type defined by this method may be provided by the present technique.
    Type: Grant
    Filed: August 19, 2009
    Date of Patent: June 11, 2013
    Assignee: General Electric Company
    Inventors: Mark Samuel Bailey, Michelle Bezdecny, Stefan Andreas Moser
  • Publication number: 20120295884
    Abstract: The present invention provides a compound of formula I: a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
    Type: Application
    Filed: January 2, 2012
    Publication date: November 22, 2012
    Applicant: NOVARTIS AG
    Inventors: Eva ALTMANN, Ulrich HOMMEL, Edwige Liliane Jeanne LORTHIOIS, Juergen Klaus MAIBAUM, Nils OSTERMANN, Jean Quancard, Stefan Andreas RANDL, Olivier ROGEL, Oliver SIMIC, Anna VULPETTI, Veronique Stark-Rogel
  • Patent number: 8309596
    Abstract: The present invention relates to the crystal structure of the serine protease kallikrein 7 and to the use of this crystal structure in drug discovery. The present invention also relates to compounds binding specifically to this active site of kallikrein 7.
    Type: Grant
    Filed: June 26, 2008
    Date of Patent: November 13, 2012
    Assignee: Novartis AG
    Inventors: Stefanie Flohr, Stefan Andreas Randl, Nils Ostermann, Ulrich Hassiepen, Frederic Berst, Ursula Bodendorf, Bernd Gerhartz, Andreas Marzinzik, Claus Ehrhardt, Josef Gottfried Meingassner
  • Patent number: D705040
    Type: Grant
    Filed: October 6, 2011
    Date of Patent: May 20, 2014
    Inventors: Walter Martin Konrad, Stefan Andreas Poetsch, Travis Lee Ewing